Abbott India Q1 Results FY27: Uniresearch Prediction and Analysis

Abbott India Q1 Results FY27 outlook from Uniresearch is anchored on verified Q4 FY26 actuals and Uniresearch trailing analysis. Uniresearch projects Abbott India Q1 FY27 Revenue Rs 1,939 Cr (+11.6% YoY) and PAT Rs 408 Cr (+11.6% YoY). Prepared by Ankit Jaiswal.

Click Here – Get Free Investment Predictions

Abbott India Q1 Results FY27 – Uniresearch Prediction

Metric	Q1 FY26 Actual	Q1 FY27 Uniresearch Prediction	YoY Change	Source
Abbott India Revenue (Rs Cr)	1,738	1,939	+11.6%	Uniresearch | Uniresearch trailing analysis
PAT (Rs Cr)	366	408	+11.6%	Uniresearch | Uniresearch trailing analysis
Avg Analyst Target	See screener	12-month view	–	Uniresearch trailing analysis

Abbott India Q4 FY26 Performance

Metric	Q4 FY26 Actual	vs Q1 FY26	Source
Revenue (Rs Cr)	1,710	-1.6%	Screener consolidated
PAT (Rs Cr)	395	+7.9%	Screener consolidated

Analyst Views and Growth Outlook

The Uniresearch trailing analysis projects Abbott India FY27 revenue at +11.6% and profit at +11.6% YoY. Uniresearch applied these growth rates to Q1 FY26 actuals to derive the Q1 FY27 prediction. Q4 FY26 actuals showed Abbott India delivering revenue of Rs 1,710 Cr and PAT of Rs 395 Cr.

Key Watchpoints

Revenue Delivery

Key question: can Abbott India reach Rs 1,939 Cr in Q1 FY27 revenue, representing +11.6% YoY growth over the Q1 FY26 base of Rs 1,738 Cr.

PAT vs Growth Target

Profit performance of Rs 408 Cr (+11.6%) vs the Q1 FY26 base of Rs 366 Cr is the profitability watchpoint for Abbott India in Q1 FY27.

Risks

Revenue Shortfall

Revenue below the +11.6% consensus would indicate sector headwinds or execution delays for Abbott India.

Margin Pressure

Cost increases or margin compression could challenge the +11.6% PAT growth projection for Abbott India in Q1 FY27.

Conclusion

The Abbott India Q1 FY27 Uniresearch projection of Revenue Rs 1,939 Cr and PAT Rs 408 Cr is derived from the Uniresearch trailing analysis. Investors should watch Q4 FY26 actuals as the base, and track Abbott India live on the Univest Screener.

Track Abbott India Live on the Univest Screener

Download the Univest iOS App or Univest Android App for live FY27 alerts.

FAQs on Abbott India Q1 Results FY27

What is Uniresearch’s PAT prediction for Abbott India Q1 Results FY27?

Ans. Uniresearch projects Abbott India Q1 FY27 PAT at Rs 408 Cr (+11.6% vs Q1 FY26 base Rs 366 Cr).

What is the Revenue forecast for Abbott India Q1 Results FY27?

Ans. Abbott India Q1 FY27 Revenue is projected at Rs 1,939 Cr (+11.6% consensus).

What were Abbott India Q4 FY26 actuals for Abbott India Q1 Results FY27?

Ans. Q4 FY26 Revenue Rs 1,710 Cr and PAT Rs 395 Cr.

How many analysts cover Abbott India Q1 Results FY27?

Ans. The prediction uses Uniresearch trailing analysis, avg target Rs 0.

What consensus applies to Abbott India Q1 Results FY27?

Ans. Revenue +11.6% and profit +11.6% (Uniresearch trailing analysis).

What are the main risks to Abbott India Q1 Results FY27?

Ans. Revenue missing +11.6% consensus and PAT pressure vs +11.6% growth target.

What is the Q1 FY26 base for Abbott India Q1 Results FY27?

Ans. Q1 FY26 Revenue Rs 1,738 Cr and PAT Rs 366 Cr.